Filing Details

Accession Number:
0000885590-13-000101
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-17 16:10:56
Reporting Period:
2013-12-14
Filing Date:
2013-12-17
Accepted Time:
2013-12-17 16:10:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1426004 Michael J. Pearson 2150 St. Elzear Blvd. West
Laval A8 H7L 4A8
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2013-12-14 184,247 $81.41 4,025,498 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This number represents the amount of shares purchased through a private transaction.